nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralatrexate—Pharyngolaryngeal pain—Telbivudine—hepatitis B	0.0428	0.0551	CcSEcCtD
Pralatrexate—Laryngeal pain—Telbivudine—hepatitis B	0.0424	0.0546	CcSEcCtD
Pralatrexate—Sepsis—Telbivudine—hepatitis B	0.0251	0.0323	CcSEcCtD
Pralatrexate—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.023	0.0296	CcSEcCtD
Pralatrexate—Pain in extremity—Telbivudine—hepatitis B	0.021	0.027	CcSEcCtD
Pralatrexate—Neutropenia—Entecavir—hepatitis B	0.0206	0.0266	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Entecavir—hepatitis B	0.0205	0.0264	CcSEcCtD
Pralatrexate—FPGS—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.0203	0.121	CbGpPWpGaD
Pralatrexate—Neutropenia—Telbivudine—hepatitis B	0.0169	0.0218	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Telbivudine—hepatitis B	0.0168	0.0217	CcSEcCtD
Pralatrexate—Back pain—Adefovir Dipivoxil—hepatitis B	0.0145	0.0187	CcSEcCtD
Pralatrexate—Sepsis—Lamivudine—hepatitis B	0.0141	0.0182	CcSEcCtD
Pralatrexate—Anaemia—Adefovir Dipivoxil—hepatitis B	0.0139	0.0179	CcSEcCtD
Pralatrexate—Leukopenia—Entecavir—hepatitis B	0.0138	0.0177	CcSEcCtD
Pralatrexate—Cough—Adefovir Dipivoxil—hepatitis B	0.0131	0.0169	CcSEcCtD
Pralatrexate—SLC19A1—blood—hepatitis B	0.0124	0.221	CbGeAlD
Pralatrexate—Back pain—Telbivudine—hepatitis B	0.0122	0.0157	CcSEcCtD
Pralatrexate—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.012	0.0154	CcSEcCtD
Pralatrexate—Anorexia—Adefovir Dipivoxil—hepatitis B	0.0117	0.015	CcSEcCtD
Pralatrexate—Cough—Telbivudine—hepatitis B	0.011	0.0142	CcSEcCtD
Pralatrexate—Dehydration—Lamivudine—hepatitis B	0.011	0.0142	CcSEcCtD
Pralatrexate—Liver function test abnormal—Lamivudine—hepatitis B	0.0109	0.0141	CcSEcCtD
Pralatrexate—Fatigue—Entecavir—hepatitis B	0.0108	0.0139	CcSEcCtD
Pralatrexate—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.0106	0.0137	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Entecavir—hepatitis B	0.0103	0.0132	CcSEcCtD
Pralatrexate—Thrombocytopenia—Telbivudine—hepatitis B	0.0101	0.013	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.01	0.0129	CcSEcCtD
Pralatrexate—Abdominal pain—Entecavir—hepatitis B	0.00991	0.0128	CcSEcCtD
Pralatrexate—Body temperature increased—Entecavir—hepatitis B	0.00991	0.0128	CcSEcCtD
Pralatrexate—Pancytopenia—Lamivudine—hepatitis B	0.00969	0.0125	CcSEcCtD
Pralatrexate—SLC19A1—liver—hepatitis B	0.00968	0.173	CbGeAlD
Pralatrexate—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00967	0.0125	CcSEcCtD
Pralatrexate—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00967	0.0125	CcSEcCtD
Pralatrexate—Neutropenia—Lamivudine—hepatitis B	0.00955	0.0123	CcSEcCtD
Pralatrexate—Asthenia—Entecavir—hepatitis B	0.009	0.0116	CcSEcCtD
Pralatrexate—Fatigue—Telbivudine—hepatitis B	0.00888	0.0114	CcSEcCtD
Pralatrexate—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00878	0.0113	CcSEcCtD
Pralatrexate—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00866	0.0112	CcSEcCtD
Pralatrexate—Epistaxis—Lamivudine—hepatitis B	0.00858	0.0111	CcSEcCtD
Pralatrexate—Diarrhoea—Entecavir—hepatitis B	0.00858	0.0111	CcSEcCtD
Pralatrexate—DHFR—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.00849	0.0505	CbGpPWpGaD
Pralatrexate—Gastrointestinal pain—Telbivudine—hepatitis B	0.00842	0.0109	CcSEcCtD
Pralatrexate—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00837	0.0108	CcSEcCtD
Pralatrexate—FPGS—blood—hepatitis B	0.00825	0.147	CbGeAlD
Pralatrexate—Abdominal pain—Telbivudine—hepatitis B	0.00814	0.0105	CcSEcCtD
Pralatrexate—Body temperature increased—Telbivudine—hepatitis B	0.00814	0.0105	CcSEcCtD
Pralatrexate—Vomiting—Entecavir—hepatitis B	0.00797	0.0103	CcSEcCtD
Pralatrexate—Rash—Entecavir—hepatitis B	0.00791	0.0102	CcSEcCtD
Pralatrexate—Dermatitis—Entecavir—hepatitis B	0.0079	0.0102	CcSEcCtD
Pralatrexate—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00778	0.01	CcSEcCtD
Pralatrexate—Rash—Adefovir Dipivoxil—hepatitis B	0.00771	0.00994	CcSEcCtD
Pralatrexate—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00771	0.00993	CcSEcCtD
Pralatrexate—Nausea—Entecavir—hepatitis B	0.00745	0.0096	CcSEcCtD
Pralatrexate—TYMS—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.0074	0.0441	CbGpPWpGaD
Pralatrexate—Asthenia—Telbivudine—hepatitis B	0.00739	0.00952	CcSEcCtD
Pralatrexate—Pruritus—Telbivudine—hepatitis B	0.00729	0.00939	CcSEcCtD
Pralatrexate—Nausea—Adefovir Dipivoxil—hepatitis B	0.00727	0.00936	CcSEcCtD
Pralatrexate—Diarrhoea—Telbivudine—hepatitis B	0.00705	0.00908	CcSEcCtD
Pralatrexate—Back pain—Lamivudine—hepatitis B	0.00688	0.00887	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—F2—hepatitis B	0.00686	0.0408	CbGpPWpGaD
Pralatrexate—Anaemia—Lamivudine—hepatitis B	0.00657	0.00847	CcSEcCtD
Pralatrexate—Vomiting—Telbivudine—hepatitis B	0.00655	0.00844	CcSEcCtD
Pralatrexate—Rash—Telbivudine—hepatitis B	0.00649	0.00837	CcSEcCtD
Pralatrexate—Dermatitis—Telbivudine—hepatitis B	0.00649	0.00836	CcSEcCtD
Pralatrexate—FPGS—liver—hepatitis B	0.00645	0.115	CbGeAlD
Pralatrexate—Leukopenia—Lamivudine—hepatitis B	0.00637	0.0082	CcSEcCtD
Pralatrexate—Cough—Lamivudine—hepatitis B	0.00621	0.008	CcSEcCtD
Pralatrexate—Nausea—Telbivudine—hepatitis B	0.00612	0.00788	CcSEcCtD
Pralatrexate—Oedema—Lamivudine—hepatitis B	0.00581	0.00748	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—ALB—hepatitis B	0.0057	0.0339	CbGpPWpGaD
Pralatrexate—Thrombocytopenia—Lamivudine—hepatitis B	0.00568	0.00732	CcSEcCtD
Pralatrexate—Anorexia—Lamivudine—hepatitis B	0.00553	0.00713	CcSEcCtD
Pralatrexate—TYMS—blood—hepatitis B	0.00541	0.0967	CbGeAlD
Pralatrexate—DHFR—blood—hepatitis B	0.00536	0.0957	CbGeAlD
Pralatrexate—SLC19A1—Folate Metabolism—IFNG—hepatitis B	0.0052	0.0309	CbGpPWpGaD
Pralatrexate—Dyspnoea—Lamivudine—hepatitis B	0.00518	0.00667	CcSEcCtD
Pralatrexate—Decreased appetite—Lamivudine—hepatitis B	0.00505	0.0065	CcSEcCtD
Pralatrexate—Fatigue—Lamivudine—hepatitis B	0.005	0.00645	CcSEcCtD
Pralatrexate—Constipation—Lamivudine—hepatitis B	0.00496	0.0064	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Lamivudine—hepatitis B	0.00475	0.00612	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—IL2—hepatitis B	0.00462	0.0275	CbGpPWpGaD
Pralatrexate—Abdominal pain—Lamivudine—hepatitis B	0.00459	0.00591	CcSEcCtD
Pralatrexate—Body temperature increased—Lamivudine—hepatitis B	0.00459	0.00591	CcSEcCtD
Pralatrexate—FPGS—Fluoropyrimidine Activity—TP53—hepatitis B	0.00439	0.0261	CbGpPWpGaD
Pralatrexate—SLC19A1—Folate Metabolism—NFKB1—hepatitis B	0.00433	0.0257	CbGpPWpGaD
Pralatrexate—TYMS—liver—hepatitis B	0.00423	0.0756	CbGeAlD
Pralatrexate—DHFR—liver—hepatitis B	0.00419	0.0749	CbGeAlD
Pralatrexate—Asthenia—Lamivudine—hepatitis B	0.00416	0.00537	CcSEcCtD
Pralatrexate—Pruritus—Lamivudine—hepatitis B	0.00411	0.00529	CcSEcCtD
Pralatrexate—Diarrhoea—Lamivudine—hepatitis B	0.00397	0.00512	CcSEcCtD
Pralatrexate—Vomiting—Lamivudine—hepatitis B	0.00369	0.00476	CcSEcCtD
Pralatrexate—Rash—Lamivudine—hepatitis B	0.00366	0.00472	CcSEcCtD
Pralatrexate—Dermatitis—Lamivudine—hepatitis B	0.00366	0.00471	CcSEcCtD
Pralatrexate—Nausea—Lamivudine—hepatitis B	0.00345	0.00444	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—TNF—hepatitis B	0.00337	0.02	CbGpPWpGaD
Pralatrexate—SLC19A1—Folate Metabolism—TP53—hepatitis B	0.00297	0.0177	CbGpPWpGaD
Pralatrexate—SLC19A1—Folate Metabolism—IL6—hepatitis B	0.00272	0.0162	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—APOBEC3G—hepatitis B	0.00248	0.0148	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—SAG—hepatitis B	0.00248	0.0148	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—F2—hepatitis B	0.00244	0.0145	CbGpPWpGaD
Pralatrexate—FPGS—Disease—APOBEC3G—hepatitis B	0.00211	0.0125	CbGpPWpGaD
Pralatrexate—FPGS—Disease—SAG—hepatitis B	0.00211	0.0125	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—ALB—hepatitis B	0.00202	0.012	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.00193	0.0115	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—AKR1B1—hepatitis B	0.00188	0.0112	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—IFNG—hepatitis B	0.00185	0.011	CbGpPWpGaD
Pralatrexate—DHFR—Fluoropyrimidine Activity—TP53—hepatitis B	0.00183	0.0109	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—GGT2—hepatitis B	0.0018	0.0107	CbGpPWpGaD
Pralatrexate—DHFR—E2F transcription factor network—CDKN2A—hepatitis B	0.00175	0.0104	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—IL2—hepatitis B	0.00164	0.00977	CbGpPWpGaD
Pralatrexate—TYMS—Fluoropyrimidine Activity—TP53—hepatitis B	0.0016	0.00953	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—AKR1B1—hepatitis B	0.0016	0.0095	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—NFKB1—hepatitis B	0.00154	0.00915	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GGT2—hepatitis B	0.00153	0.00911	CbGpPWpGaD
Pralatrexate—TYMS—E2F transcription factor network—CDKN2A—hepatitis B	0.00152	0.00907	CbGpPWpGaD
Pralatrexate—DHFR—E2F transcription factor network—CDKN1A—hepatitis B	0.00143	0.0085	CbGpPWpGaD
Pralatrexate—TYMS—E2F transcription factor network—CDKN1A—hepatitis B	0.00125	0.00741	CbGpPWpGaD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—CDKN1A—hepatitis B	0.00124	0.00738	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—TNF—hepatitis B	0.0012	0.00711	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—GOT2—hepatitis B	0.00118	0.00701	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—CYP2A6—hepatitis B	0.00109	0.00649	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.00109	0.00648	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—hepatitis B	0.00108	0.00644	CbGpPWpGaD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—CDKN2A—hepatitis B	0.00107	0.00636	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—TP53—hepatitis B	0.00105	0.00627	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.00105	0.00625	CbGpPWpGaD
Pralatrexate—DHFR—G1/S Transition—CDKN1A—hepatitis B	0.00104	0.00617	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—GOT1—hepatitis B	0.00102	0.00605	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—FAS—hepatitis B	0.00101	0.006	CbGpPWpGaD
Pralatrexate—FPGS—Disease—GOT2—hepatitis B	0.001	0.00596	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—GOT2—hepatitis B	0.000986	0.00587	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—IL6—hepatitis B	0.000965	0.00574	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—CDKN2A—hepatitis B	0.000932	0.00555	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—CYP2A6—hepatitis B	0.000927	0.00552	CbGpPWpGaD
Pralatrexate—TYMS—G1/S Transition—CDKN1A—hepatitis B	0.000904	0.00538	CbGpPWpGaD
Pralatrexate—DHFR—Disease—APOBEC3G—hepatitis B	0.00088	0.00524	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SAG—hepatitis B	0.00088	0.00524	CbGpPWpGaD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—CDKN1A—hepatitis B	0.000873	0.0052	CbGpPWpGaD
Pralatrexate—FPGS—Disease—GOT1—hepatitis B	0.000864	0.00514	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—NOS2—hepatitis B	0.000862	0.00513	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—GOT1—hepatitis B	0.000851	0.00507	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—GGT1—hepatitis B	0.000851	0.00507	CbGpPWpGaD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—TP53—hepatitis B	0.000845	0.00503	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GOT2—hepatitis B	0.000839	0.00499	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—CDKN1A—hepatitis B	0.000762	0.00453	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CCR5—hepatitis B	0.000759	0.00452	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—HLA-A—hepatitis B	0.00074	0.0044	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—TP53—hepatitis B	0.000737	0.00439	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GOT1—hepatitis B	0.000724	0.00431	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GGT1—hepatitis B	0.000724	0.00431	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—AKR1B1—hepatitis B	0.000667	0.00397	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CCR5—hepatitis B	0.000645	0.00384	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—NOS2—hepatitis B	0.000643	0.00383	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GGT2—hepatitis B	0.000639	0.0038	CbGpPWpGaD
Pralatrexate—FPGS—Disease—HLA-A—hepatitis B	0.000629	0.00374	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000591	0.00352	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—AKR1B1—hepatitis B	0.000582	0.00346	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000577	0.00343	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000576	0.00343	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000573	0.00341	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GGT2—hepatitis B	0.000558	0.00332	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—PTEN—hepatitis B	0.000553	0.00329	CbGpPWpGaD
Pralatrexate—FPGS—Disease—NOS2—hepatitis B	0.000547	0.00326	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000477	0.00284	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CD4—hepatitis B	0.000477	0.00284	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—ALB—hepatitis B	0.000453	0.0027	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000446	0.00265	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CTNNB1—hepatitis B	0.000423	0.00252	CbGpPWpGaD
Pralatrexate—DHFR—Disease—GOT2—hepatitis B	0.000418	0.00249	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CDKN1A—hepatitis B	0.000413	0.00246	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PTEN—hepatitis B	0.000413	0.00246	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CD4—hepatitis B	0.000405	0.00241	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000393	0.00234	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN2A—hepatitis B	0.000392	0.00233	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP2A6—hepatitis B	0.000387	0.00231	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—ALB—hepatitis B	0.000385	0.00229	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—TP53—hepatitis B	0.000377	0.00225	CbGpPWpGaD
Pralatrexate—DHFR—Disease—GOT1—hepatitis B	0.000361	0.00215	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CTNNB1—hepatitis B	0.00036	0.00214	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CDKN1A—hepatitis B	0.000352	0.00209	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PTEN—hepatitis B	0.000351	0.00209	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GOT2—hepatitis B	0.00035	0.00208	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN2A—hepatitis B	0.00035	0.00208	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PTEN—hepatitis B	0.000345	0.00206	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—IL6—hepatitis B	0.000345	0.00206	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—TGFB1—hepatitis B	0.000342	0.00204	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN2A—hepatitis B	0.000342	0.00203	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP2A6—hepatitis B	0.000338	0.00201	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN1A—hepatitis B	0.00032	0.00191	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GOT2—hepatitis B	0.000306	0.00182	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN2A—hepatitis B	0.000306	0.00182	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GGT1—hepatitis B	0.000302	0.0018	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GOT1—hepatitis B	0.000302	0.0018	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PTEN—hepatitis B	0.000294	0.00175	CbGpPWpGaD
Pralatrexate—FPGS—Disease—TGFB1—hepatitis B	0.000291	0.00173	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN1A—hepatitis B	0.000286	0.0017	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN1A—hepatitis B	0.000279	0.00166	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CCR5—hepatitis B	0.00027	0.0016	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GOT1—hepatitis B	0.000264	0.00157	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GGT1—hepatitis B	0.000264	0.00157	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HLA-A—hepatitis B	0.000263	0.00156	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—IL6—hepatitis B	0.000258	0.00153	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN1A—hepatitis B	0.00025	0.00149	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NOS2—hepatitis B	0.000229	0.00136	CbGpPWpGaD
Pralatrexate—FPGS—Disease—IL6—hepatitis B	0.000219	0.0013	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—TP53—hepatitis B	0.000195	0.00116	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—TP53—hepatitis B	0.00017	0.00101	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CD4—hepatitis B	0.000169	0.00101	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ALB—hepatitis B	0.000161	0.000957	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CTNNB1—hepatitis B	0.00015	0.000895	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDKN1A—hepatitis B	0.000147	0.000874	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PTEN—hepatitis B	0.000147	0.000872	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ALB—hepatitis B	0.00014	0.000835	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PTEN—hepatitis B	0.000123	0.00073	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TGFB1—hepatitis B	0.000121	0.000723	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PTEN—hepatitis B	0.000107	0.000637	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IL6—hepatitis B	9.15e-05	0.000545	CbGpPWpGaD
